ImmunoCellular Therapeutics, OverviewImmunoCellular Therapeutics, Net Income
Profitability analysis for IMUC.
Quarterly Net Income
$0
↑ 100% YoY
As of Sep 2023
Annual Net Income (TTM)
-$464525.00
↑ 78.74% YoY
Trailing 12 months ending Sep 2023
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...